Charlotte I. Stroes

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study.

Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study.

Journal: Translational oncology

Published: April 08, 2024

Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review.

Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review.

Journal: Cancer treatment reviews

Published: March 23, 2022

A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT).

A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT).

Journal: Therapeutic advances in medical oncology

Published: January 20, 2022

A systematic review of HER2 blockade for the curative treatment of gastroesophageal adenocarcinoma: Successes achieved and opportunities ahead.

A systematic review of HER2 blockade for the curative treatment of gastroesophageal adenocarcinoma: Successes achieved and opportunities ahead.

Journal: Cancer treatment reviews

Published: May 13, 2021

A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX.

A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX.

Journal: Cancers

Published: January 11, 2021

Health-related quality of life in curatively-treated patients with esophageal or gastric cancer: A systematic review and meta-analysis.

Health-related quality of life in curatively-treated patients with esophageal or gastric cancer: A systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: March 04, 2020

Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study.

Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 07, 2019

From presentation to paper: Gender disparities in oncological research.

From presentation to paper: Gender disparities in oncological research.

Journal: International journal of cancer

Published: June 07, 2019

Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study).

Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study).

Journal: Cancers

Published: April 26, 2019

Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Journal: Cancers

Published: March 21, 2019

Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with 18F-DPA-714 PET/CT.

Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with 18F-DPA-714 PET/CT.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 31, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026